|
|
|
Volumn 166, Issue , 2001, Pages 139-154
|
|
Immunotoxin treatment of brain tumors.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BACTERIAL TOXIN;
CRM 107;
DIPHTHERIA TOXIN;
DRUG CARRIER;
HYBRID PROTEIN;
IMMUNOTOXIN;
LIGAND;
MONENSIN;
TRANSFERRIN;
VEGETABLE PROTEIN;
ANIMAL;
BRAIN TUMOR;
CARCINOMA;
CELL CULTURE;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG POTENTIATION;
DRUG SCREENING;
GLIOMA;
GUINEA PIG;
HUMAN;
INTRALESIONAL DRUG ADMINISTRATION;
INTRASPINAL DRUG ADMINISTRATION;
MEDULLOBLASTOMA;
MENINGIOMA;
METASTASIS;
MOUSE;
NUDE RAT;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
RAT;
REVIEW;
TISSUE DISTRIBUTION;
TREATMENT OUTCOME;
ANIMALS;
BACTERIAL TOXINS;
BRAIN NEOPLASMS;
CARCINOMA;
CLINICAL TRIALS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
DIPHTHERIA TOXIN;
DRUG CARRIERS;
DRUG SYNERGISM;
GLIOMA;
GUINEA PIGS;
HUMANS;
IMMUNOTOXINS;
INJECTIONS, INTRALESIONAL;
INJECTIONS, SPINAL;
LIGANDS;
MEDULLOBLASTOMA;
MENINGEAL NEOPLASMS;
MICE;
MONENSIN;
PLANT PROTEINS;
RATS;
RATS, NUDE;
RECOMBINANT FUSION PROTEINS;
TISSUE DISTRIBUTION;
TRANSFERRIN;
TREATMENT OUTCOME;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
|
EID: 0035227512
PISSN: 10643745
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (11)
|
|
References (38)
|
